PHASTAR
Private Company
Total funding raised: $20M
Overview
PHASTAR is an award-winning, specialist biometrics CRO that leverages deep statistical expertise and innovative technology to support clinical development programs from design through regulatory submission. The company differentiates itself through a 'right first-time' delivery approach, a flexible and scalable service model, and a strong track record in trial rescue and quality assurance. With over 400 specialists across 15 countries, PHASTAR partners with sponsors to optimize data strategy, mitigate risk, and accelerate the path of new therapies to patients.
Technology Platform
Proprietary framework and Clinical Intelligence Portal for clinical data analysis, featuring AI-enhanced analytics, advanced statistical methods, and tools like a Recruitment Forecasting app to optimize trial delivery and data packaging for regulatory submission.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
PHASTAR competes in the specialist biometrics segment against other niche CROs like Cytel and Quanticate, as well as the large biometrics divisions of full-service CRO giants (e.g., IQVIA, Labcorp, Parexel). Its differentiation hinges on a focused 'right first-time' quality ethos, flexible service models, and a strong reputation in trial rescue.